{"role": "decision", "ts_utc": "2025-08-11T17:23:39Z", "json": {"action": "increase", "target_pos_pct": 0.1, "reasons": ["Tech score indicates potential for growth", "Strong YoY revenue and EPS growth", "Within allowed limits"], "confidence": 0.5}, "usage": {"prompt_tokens": 1053, "completion_tokens": 57, "total_tokens": 1110, "completion_tokens_details": {"audio_tokens": 0, "reasoning_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 0}}, "system": "系统：你是交易决策器。依据输入的 features、analysis 与 limits，输出合规的决策。严禁超过 limits 约束。\n要求：\n- action ∈ {\"increase\",\"hold\",\"decrease\",\"close\"}\n- 0 ≤ target_pos_pct ≤ limits.max_pos_pct\n- 若 action=\"increase\"，需满足 target_pos_pct ≥ features.position_state.current_position_pct\n- 综合考虑（但不逐条解释）：\n  - 技术面：trend/mom/ret/atr_pct/vwap_dev\n  - 情绪与事件：news.sentiment、freshness_min、src_count\n  - 基本面：fund 中的 rev/eps yoy、margin、debt_to_equity、shares_dilution_1y\n  - 风控：limits.allowed、max_pos_pct、cooldown\n只返回严格 JSON：\n{\n  \"action\": \"increase|hold|decrease|close\",\n  \"target_pos_pct\": 0.0-1.0,\n  \"reasons\": [\"...\"],\n  \"confidence\": 0.0-1.0\n}\n示例（简化）：\n输入：{\"features\":{...},\"analysis\":{\"tech_score\":0.7,\"sent_score\":0.2,\"event_risk\":\"normal\",\"confidence\":0.7},\"limits\":{\"allowed\":[\"increase\",\"hold\"],\"max_pos_pct\":0.2}}\n输出：{\"action\":\"increase\",\"target_pos_pct\":0.2,\"reasons\":[\"Tech and sentiment aligned\",\"Within limits\"],\"confidence\":0.7}\n用户：以下是单票输入 JSON（features/analysis/limits）。请直接给出上面定义的 JSON，不要输出其他内容。 ", "user": "{\"features\": {\"schema_version\": \"v1\", \"symbol\": \"MSFT\", \"ts_utc\": \"2025-01-02T00:00:00Z\", \"tech\": {\"ret\": {\"1d\": -0.006927639383155437, \"5d\": -0.04723101085744197, \"20d\": -0.029267161410018616}, \"atr_pct\": 0.02002272016343209, \"trend\": \"sideways\", \"mom\": 0.3681640066332352, \"vwap_dev\": 0.7951912088135076}, \"news\": {\"sentiment\": 0.0, \"top_k_events\": [\"The Bull Market Keeps Growing: 4 Reasons to Buy Amazon Like There's No Tomorrow\", \"Healthcare Business Collaboration Tools Market to Worth Over US$ 201.94 Billion By 2033 | Astute Analytica\", \"Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference\", \"GROUPIRA Launches Cutting-Edge Platform to Transform IRA Rollovers with Microsoft Azure\", \"2 Artificial Intelligence (AI) ETFs to Confidently Buy Heading Into 2025\"], \"src_count\": 23, \"freshness_min\": -875}, \"fund\": {\"has_dividend_30d\": 1.0, \"dividend_cash_last\": 0.83, \"dividend_yield_last\": 0.001977084871727686, \"has_split_180d\": 0.0, \"fin_rev_yoy\": 0.18097548163826538, \"fin_eps_yoy\": 0.23986486486486513, \"fin_gross_margin\": 0.6858492170432098, \"fin_op_margin\": 0.44901296424693554, \"fin_net_margin\": 0.3562616920239139, \"fin_fcf_margin\": 0.157964966444709, \"fin_debt_to_equity\": 0.12562922332951942, \"fin_shares_dilution_1y\": 0.0}, \"market_ctx\": {\"last_price\": 419.81, \"vol_zscore_20d\": -0.3629432216032252, \"realized_vol_20d\": 0.012154417592183268, \"gap_1d\": 0.00956109134045069}, \"position_state\": {\"current_position_pct\": 0.0, \"avg_price\": null, \"pnl_pct\": 0.0, \"holding_days\": 0}}, \"analysis\": {\"schema_version\": \"v1\", \"tech_score\": 0.5, \"sent_score\": 0.25, \"event_risk\": \"normal\", \"summary\": [\"Sideways trend with low momentum\", \"Strong YoY revenue/EPS growth and healthy margins\"], \"confidence\": 0.5}, \"limits\": {\"allowed\": [\"increase\", \"hold\"], \"max_pos_pct\": 0.1, \"cooldown\": false, \"hits\": [\"min_holding_days_enforced\"]}}", "raw": "{\n  \"action\": \"increase\",\n  \"target_pos_pct\": 0.1,\n  \"reasons\": [\"Tech score indicates potential for growth\", \"Strong YoY revenue and EPS growth\", \"Within allowed limits\"],\n  \"confidence\": 0.5\n}"}